Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Ashtead CEO snaps up shares

(Sharecast News) - Ashtead revealed on Thursday that chief executive officer Brendan Horgan had acquired 4,000 ordinary shares in the FTSE 100-listed industrial equipment rental firm. Horgan, who took over as CEO in May 2019, purchased the shares on Wednesday at an average price of 5,320.0p, for a total value of £212,800.

As of 1620 GMT, Ashtead shares were down 0.68% at 5,264.0p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Ashtead Group (AHT) Director name: Horgan,Brendan Amount purchased: 4,000 @ 5,320.00p Value: £212,800.00

Chesnara (CSN) Director name: Hagh,Carol Amount purchased: 10,000 @ 258.38p Value: £25,838.00

Ncc Group (NCC) Director name: Maddison ,Mike Amount purchased: 18,187 @ 136.40p Value: £24,807.07

B90 Holdings Npv (B90) Director name: McIver,Andrew Ross Amount purchased: 250,000 @ 5.00p Value: £12,500.00

Top Director Sells

Tracsis (TRCS) Director name: Barnes,Christopher Matthew Amount sold: 3,806 @ 533.00p Value: £20,285.98

Tracsis (TRCS) Director name: Kelly,Andrew Amount sold: 2,422 @ 533.00p Value: £12,909.26

Share this article

Related Sharecast Articles

Director dealings: Tracsis director snaps up shares
(Sharecast News) - Tracsis revealed on Wednesday that non-executive director Tracy Sheedy had acquired 950 ordinary shares in the AIM-listed transport software provider.
Director dealings: Admiral director raises stake
(Sharecast News) - Admiral Group revealed on Tuesday that non-executive director Justine Roberts had acquired 1,044 ordinary shares in the FTSE 100-listed insurer.
Director dealings: Creo Medical chairman raises stake
(Sharecast News) - Creo Medical revealed on Monday that chairman Kevin Crofton had acquired 1.17m ordinary shares in the London-listed medical device company.
Director dealings: Rentokil Initial director makes share purchase
(Sharecast News) - Rentokil Initial revealed on Friday that non-executive director Brian Baldwin had acquired 7.5m ordinary shares in the FTSE 100-listed pest control business.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.